KHEMANI, RG, L SMITH, YM LOPEZ-FERNANDEZ, J KWOK, R MORZOV, MJ KLEIN, N YEHYA, D WILLSON, MCJ KNEYBER, J LILLIE, A FERNANDEZ, CJL NEWTH, P JOUVET, Thomas NJ, M ALTHABE, Vera AA, P BOTTA, P CAPOCASA, P CASTELLANI, K CINQUEGRANI, SF ESPANOL, A FERNANDEZ, M FERREYRA, YV FORTINI, M GIAMPIERI, T IOLSTER, LM LANDRY, C MONJES, MJ MONTES, D ORQUEDA, F PAZIENCIA, C PEDRAZA, R POTERALA, D ROSEMARY, J SFORZA, AS SERRATE, SF TORRES, G TURON, NA VIDAL, S BARR, W BUTT, C DELZOPPO, S ERICKSON, A PINTIMALLA, S SHEA, GAG RIVERA, AFM LEON, M DUMITRASCU, G EMERIAUD, ME FRENCH, P JOUVET, C ACUNA, J ALVEAR, D CARO, IAE CASTILLO, A CORTEZ, PC ROMERO, F DIAZ, LG MUNDACA, T MEDINA, MJ NUNEZ, PP MADRID, AW ARAYA, Y CHEN, LM IZQUIERDO, YPL ALARCON, LM VEGA, RP CARRERO, GP LOZANO, BEP OLAVE, DQ LOPEZ, PV HOYOS, CZ ORREGO, Martin VAVŘINA, Jiří ŽUREK, S CAMPOS-MINO, R YEROVI, F BAUDIN, P BOURGOIN, A BRIDIER, M GENUINI, J GUICHOUX, M MARIA, C MILESI, V PAYEN, J STARCK, B TRAVERT, G BRIASSOULIS, S ILIA, A CAMPORESI, F CHIUSOLO, Nardo M DI, Y KIDA, M KYO, S OHSHIMO, N SHIME, Y TABATA, I ELGHUWAEL, LCS LUM, CW TAI, SF TANG, AEJ QUIJADA, NJJ RIVERA, S DIJKSTRA, M KNEYBER, J BECA, M REA, C SHERRING, GSI VARGAS, GR CORTEZ, J TANTALEAN, DV MIRANDA, I PAGOWSKA-KLIMEK, C CAMILO, CG ESCOBAR, MS MONIZ, Amoudi A AL, A ALAHMADTI, N ALDAIRI, T HAZWANI, R TAYLOR, DA VILLANUEVA, M BREZMES, SB SANAGUSTIN, M GABOLI, PG CASAS, MG GONZALEZ, CG ORAYEN, JMG GOMEZ, la Fuente AML DE, YL FERNANDEZ, J LOPEZ-HERCE, PM REVILLA, L MARTINEZ, Azagra AM DE, A MEDINA, M MENDIZABAL, VMI ALAPONT, AM MARTINEZ, EO VERGARA, DP ARIAS, J PARRILLA, JP ORIVE, MP ODENA, SR DOMINGUEZ, PR CAMPOY, JIS DIAZ, JR VALLE, AB ANIL, FK CAN, O DURSUN, EA ONGUN, E ABALEKE, R AGBEKO, A ARAMBURO, P BAINES, J BRIERLEY, A DEEP, TE DOMINGUEZ, B DWARAKANATHAN, C FEATHER, Y FEINSTEIN, PM FORTUNE, H GALE, D INWALD, C JENNINGS, D JONES, A LAWTON-WOODHALL, J LILLIE, D MACRAE, J MCCORKELL, K MCINTYRE, C MELLISH, R MILDNER, S ORUGANTI, J PAPPACHAN, A PLUNKETT, K SADASIVAM, V SHEWARD, C SILVESTRE, G SUBRAMANIAN, S SUNDARARAJAN, K SYKES, L WALSH, J WEITZ, KG ACKERMAN, M ADU-DARKO, JT AFFOLTER, O ALIBRAHIM, K ALLEN, C ALLEN, A AL-SUBU, H ANTHONY, N ASHTARI, M BALES, D BARRY, F BELTRAMO, L BENKEN, A BHALLA, A BLOM, E BRODEN, K BYSANI, C CARROLL, RS CHIMA, B COATES, A CORONADO-MUNOZ, M CULLIMORE, N CVIJANOVICH, MK DAHMER, WK DOCKERY, JB ESTIL, H FLORI, R GAUTAM, R GEDEIT, S GERTZ, JS GIULIANO, B GOVANTES, B HAILESELASSIE, YY HAN, A HARRELL, S HARTMANN, G HEFLEY, G HENDERSON, DD HSING, A HUGHES-SCHALK, J HUME, S JAFARI-NAMIN, N JAIMON, JD JARVIS, C JAYACHANDRAN, AS JEYAPALAN, M KASCH, J KEARY, C KELLEY, A KESSEL, R KHEMANI, C KING, A KNIOLA, K KRALLMAN, S KUBIS, L KUSTKA, J KWOK, S LATIFI, Lin JC, AB MADDUX, S MAHAPATRA, C MERRITT, T MONJURE, R MORGAN, R MORZOV, PM MOURANI, K MURKOWSKI, M MURPHY, N NAPOLITANO, D NERHEIM, ST NETT, C NEWTH, R NOFZIGER, MM PARKER, N PATANKAR, N PINTO, S PON, H QIAO, K RALSTON, A RATIU, C RODGERS, L RONAN, C ROWAN, R SANDERS, J SANTANELLI, A SAPRU, J SCHNEIDER, SL SHEIN, A SHUKLA, Y SIERRA, L SIKORA, M SINGLETON, D SLONIEWSKY, R SMITH, L SMITH, H SONG, M SPAEDER, D SPEAR, P SPINELLA, E STONEMAN, F SU, E SULLIVAN, T SWEBERG, J TALA, N THOMAS, KS TIEVES, L TORERO, B TOTAPALLY, E TRUEMPER, K TYPPO, M VIRK, L WELLISCH, D WILLSON, K WOODS, N YEHYA a T YUNGER. Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study. LANCET RESPIRATORY MEDICINE. OXFORD: ELSEVIER SCI LTD, 2019, roč. 7, č. 2, s. 115-128. ISSN 2213-2600. Dostupné z: https://dx.doi.org/10.1016/S2213-2600(18)30344-8.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study
Autoři KHEMANI, RG, L SMITH, YM LOPEZ-FERNANDEZ, J KWOK, R MORZOV, MJ KLEIN, N YEHYA, D WILLSON, MCJ KNEYBER, J LILLIE, A FERNANDEZ, CJL NEWTH, P JOUVET, Thomas NJ, M ALTHABE, Vera AA, P BOTTA, P CAPOCASA, P CASTELLANI, K CINQUEGRANI, SF ESPANOL, A FERNANDEZ, M FERREYRA, YV FORTINI, M GIAMPIERI, T IOLSTER, LM LANDRY, C MONJES, MJ MONTES, D ORQUEDA, F PAZIENCIA, C PEDRAZA, R POTERALA, D ROSEMARY, J SFORZA, AS SERRATE, SF TORRES, G TURON, NA VIDAL, S BARR, W BUTT, C DELZOPPO, S ERICKSON, A PINTIMALLA, S SHEA, GAG RIVERA, AFM LEON, M DUMITRASCU, G EMERIAUD, ME FRENCH, P JOUVET, C ACUNA, J ALVEAR, D CARO, IAE CASTILLO, A CORTEZ, PC ROMERO, F DIAZ, LG MUNDACA, T MEDINA, MJ NUNEZ, PP MADRID, AW ARAYA, Y CHEN, LM IZQUIERDO, YPL ALARCON, LM VEGA, RP CARRERO, GP LOZANO, BEP OLAVE, DQ LOPEZ, PV HOYOS, CZ ORREGO, Martin VAVŘINA, Jiří ŽUREK, S CAMPOS-MINO, R YEROVI, F BAUDIN, P BOURGOIN, A BRIDIER, M GENUINI, J GUICHOUX, M MARIA, C MILESI, V PAYEN, J STARCK, B TRAVERT, G BRIASSOULIS, S ILIA, A CAMPORESI, F CHIUSOLO, Nardo M DI, Y KIDA, M KYO, S OHSHIMO, N SHIME, Y TABATA, I ELGHUWAEL, LCS LUM, CW TAI, SF TANG, AEJ QUIJADA, NJJ RIVERA, S DIJKSTRA, M KNEYBER, J BECA, M REA, C SHERRING, GSI VARGAS, GR CORTEZ, J TANTALEAN, DV MIRANDA, I PAGOWSKA-KLIMEK, C CAMILO, CG ESCOBAR, MS MONIZ, Amoudi A AL, A ALAHMADTI, N ALDAIRI, T HAZWANI, R TAYLOR, DA VILLANUEVA, M BREZMES, SB SANAGUSTIN, M GABOLI, PG CASAS, MG GONZALEZ, CG ORAYEN, JMG GOMEZ, la Fuente AML DE, YL FERNANDEZ, J LOPEZ-HERCE, PM REVILLA, L MARTINEZ, Azagra AM DE, A MEDINA, M MENDIZABAL, VMI ALAPONT, AM MARTINEZ, EO VERGARA, DP ARIAS, J PARRILLA, JP ORIVE, MP ODENA, SR DOMINGUEZ, PR CAMPOY, JIS DIAZ, JR VALLE, AB ANIL, FK CAN, O DURSUN, EA ONGUN, E ABALEKE, R AGBEKO, A ARAMBURO, P BAINES, J BRIERLEY, A DEEP, TE DOMINGUEZ, B DWARAKANATHAN, C FEATHER, Y FEINSTEIN, PM FORTUNE, H GALE, D INWALD, C JENNINGS, D JONES, A LAWTON-WOODHALL, J LILLIE, D MACRAE, J MCCORKELL, K MCINTYRE, C MELLISH, R MILDNER, S ORUGANTI, J PAPPACHAN, A PLUNKETT, K SADASIVAM, V SHEWARD, C SILVESTRE, G SUBRAMANIAN, S SUNDARARAJAN, K SYKES, L WALSH, J WEITZ, KG ACKERMAN, M ADU-DARKO, JT AFFOLTER, O ALIBRAHIM, K ALLEN, C ALLEN, A AL-SUBU, H ANTHONY, N ASHTARI, M BALES, D BARRY, F BELTRAMO, L BENKEN, A BHALLA, A BLOM, E BRODEN, K BYSANI, C CARROLL, RS CHIMA, B COATES, A CORONADO-MUNOZ, M CULLIMORE, N CVIJANOVICH, MK DAHMER, WK DOCKERY, JB ESTIL, H FLORI, R GAUTAM, R GEDEIT, S GERTZ, JS GIULIANO, B GOVANTES, B HAILESELASSIE, YY HAN, A HARRELL, S HARTMANN, G HEFLEY, G HENDERSON, DD HSING, A HUGHES-SCHALK, J HUME, S JAFARI-NAMIN, N JAIMON, JD JARVIS, C JAYACHANDRAN, AS JEYAPALAN, M KASCH, J KEARY, C KELLEY, A KESSEL, R KHEMANI, C KING, A KNIOLA, K KRALLMAN, S KUBIS, L KUSTKA, J KWOK, S LATIFI, Lin JC, AB MADDUX, S MAHAPATRA, C MERRITT, T MONJURE, R MORGAN, R MORZOV, PM MOURANI, K MURKOWSKI, M MURPHY, N NAPOLITANO, D NERHEIM, ST NETT, C NEWTH, R NOFZIGER, MM PARKER, N PATANKAR, N PINTO, S PON, H QIAO, K RALSTON, A RATIU, C RODGERS, L RONAN, C ROWAN, R SANDERS, J SANTANELLI, A SAPRU, J SCHNEIDER, SL SHEIN, A SHUKLA, Y SIERRA, L SIKORA, M SINGLETON, D SLONIEWSKY, R SMITH, L SMITH, H SONG, M SPAEDER, D SPEAR, P SPINELLA, E STONEMAN, F SU, E SULLIVAN, T SWEBERG, J TALA, N THOMAS, KS TIEVES, L TORERO, B TOTAPALLY, E TRUEMPER, K TYPPO, M VIRK, L WELLISCH, D WILLSON, K WOODS, N YEHYA a T YUNGER.
Vydání LANCET RESPIRATORY MEDICINE, OXFORD, ELSEVIER SCI LTD, 2019, 2213-2600.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 25.094
Doi http://dx.doi.org/10.1016/S2213-2600(18)30344-8
UT WoS 000457172000022
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnil: MUDr. Martin Vavřina, učo 73806. Změněno: 19. 4. 2021 13:40.
Anotace
Background Paediatric acute respiratory distress syndrome (PARDS) is associated with high mortality in children, but until recently no paediatric-specific diagnostic criteria existed. The Pediatric Acute Lung Injury Consensus Conference (PALICC) definition was developed to overcome limitations of the Berlin definition, which was designed and validated for adults. We aimed to determine the incidence and outcomes of children who meet the PALICC definition of PARDS. Methods In this international, prospective, cross-sectional, observational study, 145 paediatric intensive care units (PICUs) from 27 countries were recruited, and over a continuous 5 day period across 10 weeks all patients were screened for enrolment. Patients were included if they had a new diagnosis of PARDS that met PALICC criteria during the study week. Exclusion criteria included meeting PARDS criteria more than 24 h before screening, cyanotic heart disease, active perinatal lung disease, and preparation or recovery from a cardiac intervention. Data were collected on the PICU characteristics, patient demographics, and elements of PARDS (ie, PARDS risk factors, hypoxaemia severity metrics, type of ventilation), comorbidities, chest imaging, arterial blood gas measurements, and pulse oximetry. The primary outcome was PICU mortality. Secondary outcomes included 90 day mortality, duration of invasive mechanical and non-invasive ventilation, and cause of death. Findings Between May 9, 2016, and June 16, 2017, during the 10 study weeks, 23 280 patients were admitted to participating PICUs, of whom 744 (3.2%) were identified as having PARDS. 95% (708 of 744) of patients had complete data for analysis, with 17% (121 of 708; 95% CI 14-20) mortality, whereas only 32% (230 of 708) of patients met Berlin criteria with 27% (61 of 230) mortality. Based on hypoxaemia severity at PARDS diagnosis, mortality was similar among those who were non-invasively ventilated and with mild or moderate PARDS (10-15%), but higher for those with severe PARDS (33% [54 of 165; 95% CI 26-41]). 50% (80 of 160) of non-invasively ventilated patients with PARDS were subsequently intubated, with 25% (20 of 80; 95% CI 16-36) mortality. By use of PALICC PARDS definition, severity of PARDS at 6 h after initial diagnosis (area under the curve [AUC] 0.69, 95% CI 0.62-0.76) discriminates PICU mortality better than severity at PARDS diagnosis (AUC 0.64, 0.58-0.71), and outperforms Berlin severity groups at 6 h (0.64, 0.58-0.70; p= 0.01). Interpretation The PALICC definition identified more children as having PARDS than the Berlin definition, and PALICC PARDS severity groupings improved the stratification of mortality risk, particularly when applied 6 h after PARDS diagnosis. The PALICC PARDS framework should be considered for use in future epidemiological and therapeutic research among children with PARDS.
VytisknoutZobrazeno: 18. 7. 2024 00:34